SCHEMBL417467

SCHEMBL417467

NNS(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.59
CA2 P00918 3/20 0.59
CA12 O43570 2/20 0.59
CA9 Q16790 2/20 0.59
MMP1 P03956 4/20 0.55
GAA P10253 2/20 0.55
MMP12 P39900 2/20 0.55
UQCRB P14927 2/20 0.53
MEN1 O00255 1/20 0.53
MAPT P10636 1/20 0.53
MAPK1 P28482 1/20 0.53
HTT P42858 1/20 0.53
RECQL P46063 1/20 0.53
KMT2A Q03164 1/20 0.53
MMP2 P08253 8/20 0.51
ADAMTS4 O75173 2/20 0.51
CA14 Q9ULX7 1/20 0.51
SLC1A3 P43003 1/20 0.51
SLC1A2 P43004 1/20 0.51
SLC1A1 P43005 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3065124 0.91 ALDH1A1 (0.53) CA1CA2CA12CA9MMP1
SCHEMBL30724544 0.86 CA1 (0.58) CA1CA2CA12CA9MMP1
SCHEMBL1109 0.86 CA1 (0.58) CA1CA2CA12CA9MMP1
Water SCHEMBL1434222 0.84 CA1 (0.56) CA1CA2CA12CA9MMP1
Hydrochloric Acid SCHEMBL4638988 0.84 CA1 (0.56) CA1CA2CA12CA9MMP1
Hydrazine SCHEMBL28166174 0.84 CA1 (0.56) CA1CA2CA12CA9MMP1
SCHEMBL29171227 0.84 CA1 (0.56) CA1CA2CA12CA9MMP1
Potassium SCHEMBL30724545 0.84 CA1 (0.56) CA1CA2CA12CA9MMP1
SCHEMBL29171225 0.84 CA1 (0.56) CA1CA2CA12CA9MMP1
SCHEMBL28202553 0.84 CA1 (0.56) CA1CA2CA12CA9MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117535689-A Method for synthesizing sulfonamide through decarbonylation of N, N-dimethylformamide and denitrification of sulfonyl hydrazide under electrochemical condition 湘潭大学 2024-02-09 CN claimed
CN-116162046-A Alkynyl sulfone derivative and preparation method and application thereof 云南民族大学 2023-05-26 CN claimed
CN-113583309-A Novel breathable waterproof rubber composite material and preparation method thereof 青岛科技大学 2021-11-02 CN claimed
CN-113308032-A Novel breathable waterproof rubber composite material and preparation method thereof 青岛科技大学 2021-08-27 CN claimed
CN-116162046-B Alkynyl sulfone derivative and preparation method and application thereof 云南民族大学 2025-06-13 CN disclosed
CN-117535689-A Method for synthesizing sulfonamide through decarbonylation of N, N-dimethylformamide and denitrification of sulfonyl hydrazide under electrochemical condition 湘潭大学 2024-02-09 CN disclosed
CN-116162046-A Alkynyl sulfone derivative and preparation method and application thereof 云南民族大学 2023-05-26 CN disclosed
CN-114016058-B Method for electrochemically synthesizing alkyl sulfone compound 桂林医学院 2022-12-16 CN disclosed
CN-112341376-B Preparation method of cycloolefine amine sulfone derivative 温州医科大学 2022-12-06 CN disclosed
CN-114874630-A High-rate platinum heat-vulcanized foamed silicone rubber and preparation method thereof 浙江恒业成有机硅有限公司 2022-08-09 CN disclosed
CN-114016058-A Method for electrochemically synthesizing alkyl sulfone compound 桂林医学院 2022-02-08 CN disclosed
CN-113583309-A Novel breathable waterproof rubber composite material and preparation method thereof 青岛科技大学 2021-11-02 CN disclosed
US-20110118505-A1 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses SIGA TECHNOLOGIES INC. (US) 2011-05-19 US disclosed
US-20100256096-A1 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses SIGA TECHNOLOGIES, INC. 2010-10-07 US disclosed
CN-101641092-A Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods of treating hemorrhagic fever viruses, including treatment of arenavirus-associated infections SIGA TECHNOLOGIES INC US 2010-02-03 CN disclosed
EP-2124921-A2 SULFONYL SEMICARBAZIDES, CARBONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2009-12-02 EP disclosed
US-20090203675-A1 Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses SIGA TECHNOLOGIES, INC. (US) 2009-08-13 US disclosed
WO-2008147474-A2 SULFONYL SEMICARBAZIDES, CARBONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2008-12-04 WO disclosed
EP-1827446-A2 SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2007-09-05 EP disclosed
WO-2006062898-A2 COMPOUNDS AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES SIGA TECHNOLOGIES, INC. (US) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118505-A1 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses SORD, GBA1, GK CA1 4154/4885CA2 3268/4885CA12 3486/4885
US-20100256096-A1 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses GBA1, SORD, GK CA1 4296/4885CA2 3236/4885CA12 3319/4885
US-20090203675-A1 Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses GBA1, GK, GCK CA1 3702/4885CA2 3360/4885CA12 3356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.